The constant over-review of generic drugs is further promoting the industry reshuffle!

[Pharmaceutical Network Market Analysis] In recent years, with the continuous advancement of the state's policy of encouraging the preferential purchase and use of reviewed drugs, a large number of pharmaceutical companies have begun to actively participate in it in order to enhance market competitiveness and expand market sha.
Recently, China Resources Sanjiu announced that its wholly-owned subsidiary Shenzhen China Resources Jiuxin Pharmaceutical .
, L.
"cefotaxime sodium for injection" passed the consistency evaluation of generic dru.
This is the company's third product that has passed the consistency evaluation of generic drugs after "ceftazidime for injection" and "ceftazidime sodium for injectio.
On May 5, Lisheng Pharmaceutical also issued an announcement stating that the company has recently received the "Approval Notice of Drug Supplementary Application" issued by the State Drug Administration for Donepezil Hydrochloride Tablets 5.
The drug has passed the quality and efficacy consistency evaluation of generic dru.

The disclosure shows that the indications for donepezil hydrochloride tablets involve the treatment of mild, moderate or severe Alzheimer's disease sympto.
Data show that donepezil hydrochloride is a second-generation cholinesterase inhibitor, clinically used for the treatment of mild, moderate or severe Alzheimer's disease sympto.
Lisheng Pharmaceutical stated that the company's drug passed the quality and efficacy consistency evaluation of generic drugs, which is conducive to enhancing the market competitiveness of the dr.
It is understood that there are many pharmaceutical companies that have over-reviewed drugs recent.
For example, Teyi Pharmaceutical announced not long ago that it has recently obtained the “Approval Notice of Drug Supplementary Application” for “Aluminum Magnesium Carbonate Chewable Tablets” approved and issued by the State Drug Administrati.
After review, the above-mentioned drugs passed the consistency evaluation of the quality and efficacy of chemical generic dru.
In addition, Jianyou .
, L.
also recently announced that the company has recently received the approval and issuance of the "Approval Notice for Supplementary Drug Application" from the State Food and Drug Administrati.
The company's enoxaparin sodium injection has passed the quality and efficacy consistency evaluation of generic drug.

For the above-mentioned large number of generic drug over-evaluations, the industry believes that the current consistency evaluation of generic drugs in my country is progressing smoothly, and the enthusiasm of pharmaceutical companies to participate in the consistency evaluation is constantly improvi.

In fact, more than 300 drugs have been reviewed this ye.
According to the data, in April, a total of 144 approval documents passed/deemed to pass the consistency evaluation, involving 84 varieties of 93 enterprises, of which 16 varieties were first review.
In February, a total of 89 approval documents passed/deemed to pass the consistency evaluation, involving 60 varieties of 60 companies, of which 13 varieties were first review.
In addition, 88 new consistency evaluation acceptance numbers were added in January; 150 approvals (including 57 deemed approved) were reviewed; a total of 95 varieties from 97 companies were involved, of which 17 were first review.

It should be noted that, as pharmaceutical companies accelerate the promotion of generic drug consistency evaluation, the industry believes that this will also bring about a major reshuffle of China's generic drug industry, and small and medium-sized enterprises with low competitiveness will be eliminated continuously in the futu.
The market share of generic drugs will continue to increa.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.